Chemical Compound
Mixture of (R)-4-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and (R)-5-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid
Primary record
Mixture of (R)-4-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and (R)-5-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid
- 库存
- 550 克
- 纯度
- 98.1 %
化合物标识与属性
- PubChem CID
- 167312465
- SMILES
- CCN1C2=CC=CC=C2C=C1C3=NC4=C(N3CCCNC(=O)CCCCCNC(=O)C5=CC(=C(C=C5)C(=O)O)C6=C7C=CC(=O)C=C7OC8=C6C=CC(=C8)O)C=CC(=C4)C(=O)N9CCC[C@H](C9)N.CCN1C2=CC=CC=C2C=C1C3=NC4=C(N3CCCNC(=O)CCCCCNC(=O)C5=CC(=C(C=C5)C6=C7C=CC(=O)C=C7OC8=C6C=CC(=C8)O)C(=O)O)C=CC(=C4)C(=O)N9CCC[C@H](C9)N
- Canonical SMILES
- CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2CCCNC(=O)CCCCCNC(=O)c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)cc2ccccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2CCCNC(=O)CCCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)cc2ccccc21
名称与同义词
- PAD4 inhibitor GSK215
- FT-GSK215
- GLXC-27054
- Mixture of (R)-4-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and (R)-5-((6-((3-(5-(3-aminopiperidine-1-carbonyl)-2-(1-ethyl-1H-indol-2-yl)-1H-benzo[d]imidazol-1-yl)propyl)amino)-6-oxohexyl)carbamoyl)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid